Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C
Recently, a IL28B (rs 12979860) gene polymorphism was identified as a predictor for response to hepatits C virus—specific treatment in human immunodeficiency virus (HIV)—uninfected and —infected patients with chronic hepatitis C. In an analysis of HIV-infected patients with acute hepatitis C, we fou...
Saved in:
Published in | The Journal of infectious diseases Vol. 203; no. 5; pp. 595 - 601 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.03.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Recently, a IL28B (rs 12979860) gene polymorphism was identified as a predictor for response to hepatits C virus—specific treatment in human immunodeficiency virus (HIV)—uninfected and —infected patients with chronic hepatitis C. In an analysis of HIV-infected patients with acute hepatitis C, we found that the IL28B genotype was associated with serum levels of hepatitis C virus RNA, g-GT, and CD4 cell count. In contrast to HIV-infected patients with chronic hepatitis C, the IL28B genotype was not significantly associated with treatment response rates in patients with acute hepatitis C. Thus, effects of the IL28B single-nucleotide polymorphism may differ in HIV-infected patients with chronic and acute hepatitis C. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Potential conflicts of interest: none reported. Presented in part: 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, February 2010 (Abstract 164). |
ISSN: | 0022-1899 1537-6613 1537-6613 0022-1899 |
DOI: | 10.1093/infdis/jiq098 |